The hypertonic saline trial: a possible downside to the gold standard of double blinding.
James W
JW
Holcroft
D017732:Air Ambulances; D000818:Animals; D002423:Cause of Death; D003131:Combined Modality Therapy; D003911:Dextrans / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D057239:Early Termination of Clinical Trials; D004632:Emergency Medical Services / Q000592:standards; D006452:Hemoglobinometry; D006982:Hypertonic Solutions / Q000008:administration & dosage / Q000009:adverse effects; D010215:Papio; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage* / Q000009:adverse effects; D012769:Shock / Q000401:mortality / Q000628:therapy*; D012774:Shock, Traumatic / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D003911:Dextrans; D006982:Hypertonic Solutions; D012462:Saline Solution, Hypertonic